2017-08-30
Daiichi Sankyo Enters Worldwide Licensing Agreement with Boston Pharmaceuticals for a Highly Selective RET Inhibitor for Solid Tumors
2017-07-25
Gurnet Point L.P. Completes Acquisition of Innocoll Holdings plc
2017-04-05
Gurnet Point L.P. enters into agreement to acquire Innocoll Holdings plc
2016-12-07
Gurnet Point Invests $92M in Primary Care Innovator Crossover Health
2016-11-15
Gurnet Point Capital Invests in BEFORE Brands
2015-11-19
Gurnet Point Capital launches new drug development company, Boston Pharmaceuticals
2015-06-23
Gurnet Point appoints Chris Viehbacher to lead healthcare investment strategy
